Evidence map›Paper›PMID 15520467›Full record

ArticleNucleic acids research2004

Alleviation of restriction by DNA condensation and non-specific DNA binding ligands.

Steven A Keatch, Tsueu-Ju Su, David T F Dryden

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Nucleic acids research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. How bacteria control the CRISPR-Cas arsenal.Current opinion in microbiology · 2018
    Review
  3. Promiscuous restriction is a cellular defense strategy that confers fitness advantage to bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Steven A KeatchSchool of Chemistry, The University of Edinburgh, The King's Buildings, Edinburgh, EH9 3JJ, UK.
Tsueu-Ju Su
David T F Dryden
University of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council C17860
6 · The paper itself

Abstract

During conditions of cell stress, the type I restriction and modification enzymes of bacteria show reduced, but not zero, levels of restriction of unmethylated foreign DNA. In such conditions, chemically identical unmethylated recognition sequences also occur on the chromosome of the host but restriction alleviation prevents the enzymes from destroying the host DNA. How is this distinction between chemically identical DNA molecules achieved? For some, but not all, type I restriction enzymes, alleviation is partially due to proteolytic degradation of a subunit of the enzyme. We identify that the additional alleviation factor is attributable to the structural difference between foreign DNA entering the cell as a random coil and host DNA, which exists in a condensed nucleoid structure coated with many non-specific ligands. The type I restriction enzyme is able to destroy the 'naked' DNA using a complex reaction linked to DNA translocation, but this essential translocation process is inhibited by DNA condensation and the presence of non-specific ligands bound along the DNA.

Indexed as

Adenosine TriphosphateDeoxyribonucleases, Type I Site-SpecificDNADNA Restriction EnzymesIntercalating AgentsKineticsLigandsNucleic Acid ConformationPlasmidsAdenosine TriphosphateDeoxyribonucleases, Type I Site-SpecificDNADNA Restriction Enzymesendodeoxyribonuclease EcoKIIntercalating AgentsLigands

Identifiers

PMID15520467
PMCPMC528803
OpenAlexW2161236135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.